SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011556
Filing Date
2023-06-29
Accepted
2023-06-29 08:36:52
Documents
13
Period of Report
2023-06-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20230628x8k.htm   iXBRL 8-K 91302
2 EX-10.1 nrbo-20230628xex10d1.htm EX-10.1 83342
  Complete submission text file 0001558370-23-011556.txt   313528

Data Files

Seq Description Document Type Size
3 EX-101.SCH nrbo-20230628.xsd EX-101.SCH 3149
4 EX-101.LAB nrbo-20230628_lab.xml EX-101.LAB 15929
5 EX-101.PRE nrbo-20230628_pre.xml EX-101.PRE 10072
7 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20230628x8k_htm.xml XML 4880
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 231054412
SIC: 2834 Pharmaceutical Preparations